Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Department
LocationCancer and Hematology Center
Brain Tumor Program
Ewing Sarcoma Center
Rare Tumors Program
Soft Tissue Sarcoma Program
Solid Tumor Programs
Texas Medical Center
Specialty
Cancer and Hematology
Phone: 832-822-4242
Fax: 832-825-4202
Email
mfokcu@texaschildrens.org
Address
6701 Fannin St., Ste. 1510
Houston, TX 77030
Research Area
Mehmet Fatih Okcu, MD, MPH
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| University of Texas Medical School at Houston | Other | Master of Public Health | 2000 |
| University of Texas MD Anderson Cancer Center | Fellowship | Pediatric Hematology Oncology | 1999 |
| University of Texas Medical School at Houston | Residency | Pediatrics | 1995 |
| University of Texas Medical School at Houston | Internship | Pediatrics | 1993 |
| Istanbul University-Turkey | Medical School | Doctor of Medicine | 1989 |
About
Dr. Fatih Okcu's longstanding clinical interest and expertise is in brain tumors and solid tumors. He treats all subtypes of brain tumors, and has a special interest in soft tissue sarcomas, Ewing sarcoma, malignant melanoma and rare pediatric cancers. Dr. Fatih Okcu is a member of the Epidemiology and Population Sciences Program, the Solid Tumor Programs, the Long Term Survivor Program, and the Brain Tumor Program.
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Clinical Oncology (ASCO) | Member |
| American Society of Pediatric Hematology-Oncology (ASPHO) | Member |
| Children’s Oncology Group (COG) | Member |
| Society for Neuro-Oncology (SNO) | Member |
Research Statement
Dr. Fatih Okcu has ongoing studies include late effects after proton radiation therapy in brain tumor patients, reasons for lack of adherence to follow up care in survivors and relationship between genetic polymorphisms and late permanent treatment effects in childhood cancer survivors.
Research Interests
- Molecular cancer epidemiology
- Genetic polymorphisms that modify therapy modalities
- Adverse events secondary to treatment
- Neurocognitive impairments in childhood long-term survivors
Selected Publications
Awards & Honors
2019 Fellows Excellence in Education Award, Texas Children’s Cancer and Hematology Center
2013 Teaching and Evaluation, Fullbright and Javorski Award, Baylor College of Medicine
2013 Fellows Excellence in Education Award, Texas Children’s Cancer and Hematology Center
2009 Faculty Recognition Award for Excellence in Teaching, Texas Children’s Cancer Center and Hematology Service
2008 International Society of Pediatric NeuroOncology
1997 The Scott Carter Fellowship Award, National Childhood Cancer Foundation
Board Certification
American Board of Pediatrics - Pediatric Hematology-Oncology
Language
English, Turkish
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.